BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2106392)

  • 1. Lysing of fresh human tumor by a cytotoxic factor derived from autologous large granular lymphocytes independently of other known cytokines.
    Uchida A; Fujimoto T; Mizutani Y
    Cancer Immunol Immunother; 1990; 31(1):60-4. PubMed ID: 2106392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of cytotoxic factor by human large granular lymphocytes during interaction with autologous tumor cells: lysis of fresh human tumor cells.
    Uchida A; Klein E
    J Natl Cancer Inst; 1988 Nov; 80(17):1398-403. PubMed ID: 3262773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of NK cell cytotoxic factor against fresh human tumors.
    Uchida A; Fukata H
    Nat Immun; 1993; 12(4-5):267-78. PubMed ID: 8257831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti-interleukin-1 (IL-1) influences on direct and indirect IL-1-mediated islet effects.
    Kawahara DJ; Kenney JS
    Cytokine; 1991 Mar; 3(2):117-24. PubMed ID: 1888882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
    Mandrup-Poulsen T; Bendtzen K; Dinarello CA; Nerup J
    J Immunol; 1987 Dec; 139(12):4077-82. PubMed ID: 3320203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
    Uchida A; Moore M
    Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
    Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB
    J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granules of human CD3+ large granular lymphocytes contain a macrophage regulating factor(s) that induces macrophage H2O2 production and tumoricidal activity but decreases cell surface Ia antigen expression.
    Roussel E; Greenberg AH
    Cell Immunol; 1991 Apr; 134(1):31-41. PubMed ID: 1826466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
    Chong AS; Scuderi P; Grimes WJ; Hersh EM
    J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
    Ostensen ME; Thiele DL; Lipsky PE
    J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
    Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
    J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor.
    Djeu JY; Blanchard DK
    J Immunol; 1987 Oct; 139(8):2761-7. PubMed ID: 2443572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of multiple cytokines by clones of human large granular lymphocytes.
    Allavena P; Scala G; Djeu JY; Procopio AD; Oppenheim JJ; Herberman RB; Ortaldo JR
    Cancer Immunol Immunother; 1985; 19(2):121-6. PubMed ID: 3921231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha.
    Brinchmann JE; Gaudernack G; Vartdal F
    J Acquir Immune Defic Syndr (1988); 1991; 4(5):480-8. PubMed ID: 1673156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.
    Kariya Y; Okamoto N; Fujimoto T; Inoue N; Kihara T; Sugie K; Yagita M; Kanzaki H; Mori T; Uchida A
    Jpn J Cancer Res; 1991 Sep; 82(9):1044-50. PubMed ID: 1938599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.